- The key vendors in the Global Continuous Glucose Monitoring Market 2014-2018 are Abbott Laboratories, DexCom Inc. and Medtronic Inc.
London, 08 October 2014: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Continuous Glucose Monitoring Market 2014-2018. One major trend emerging in the market is the use of artificial pancreas technology in continuous glucose monitoring systems. The artificial pancreas is a closed-loop insulin delivery system that mimics the functions of a healthy pancreas in the human body by continuously monitoring glucose levels and automatically adjusting insulin delivery with minimal or no patient interaction. The market is expected to post a CAGR of 14.74 percent during the forecast period of 2013-2018.
Continuous glucose monitoring is the measurement of glucose levels at regular intervals in a diabetic patient. Continuous glucose monitoring systems allow individuals to gain insight into the trends of their glucose levels between fingersticks, resulting in improved glucose control. The system comprises a glucose sensor that is placed subcutaneously to provide readings of glucose levels in tissue fluid.
“Most continuous glucose monitoring systems employ minimally invasive approaches and use subcutaneous sensors for determining the glucose concentration in the interstitial fluid,” says Faisal Ghaus, Vice President of TechNavio Research.
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
